Replies to post #535904 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

They were also late stage patients headed to hospice. It is very possible, perhaps likely, that earlier stage patients would do even better.

[dennisdave]

Not so

Yes so. In science, for RA's and for markets (although as I have said for 3 years mr Market does not even seem to care that much anymore about positive readout of data aka positive TLD, but is only interested in the question where and when comes the money in to set the SP higher) anyway as I was saying in science, for RA's and for Mr Market meeting of endpoints as formulated in SAP aka positive topline data is what counts, not a suspicion of what may be as what you suggest.

You are not the first one asserting NWBO has reported positive topline data for other cancer indications than GBM. That's a false assumption.

This did happen for GBM
https://nwbio.com/northwest-biotherapeutics-reports-positive-top-line-results-from-phase-3-trial-of-dcvax-l-for-glioblastoma/

NOT for other cancer indications for DCVAX.
Asserting anything else is false.